Breaking News, Trials & Filings

Trials & Filings: Oct. 22, 2013

Medivation, Astellas, Regeneron

Phase III
EYLEA achieves primary endpoint in BRVO study… read more

Medivation, Astellas PREVAIL trial meets co-primary endpoints… read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters